Another PBM Favors Sandoz And Boehringer On Adalimumab

Humira Rivals Hyrimoz And Cyltezo Get Preferred Status From Express Scripts

 
• By David Wallace
  
Express Scripts Headquarters
Express Scripts has awarded preferred status to Sandoz and Boehringer’s biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products